Related Experiment Video
Updated: Nov 16, 2025

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes
Klaus F Kofoed1, Thomas Engstrøm2, Per E Sigvardsen2
1Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Radiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Insights
Coronary computed tomography angiography (CTA) is as effective as invasive coronary angiography (ICA) for assessing long-term risk in non-ST-segment elevation acute coronary syndrome (NSTEACS) patients. This finding supports CTA as a valuable tool for risk stratification in NSTEACS.
Area of Science:
- Cardiology
- Medical Imaging
- Clinical Trials
Background:
- Coronary artery disease (CAD) severity and extent, typically assessed via invasive coronary angiography (ICA), guide treatment and predict outcomes in non-ST-segment elevation acute coronary syndrome (NSTEACS).
- Risk assessment in NSTEACS is crucial for guiding clinical management and improving patient prognosis.
Purpose of the Study:
- To test the hypothesis that coronary computed tomography angiography (CTA) is equivalent to ICA for risk assessment in patients with NSTEACS.
- To evaluate the role of CTA in stratifying risk based on CAD severity and extent in NSTEACS.
Main Methods:
- The VERDICT trial enrolled 978 patients with NSTEACS, performing both coronary CTA and ICA.
- CAD severity was defined as obstructive (stenosis ≥50%) or nonobstructive; extent was high-risk (e.g., left main or multivessel disease) or non-high-risk.
- The primary endpoint was a composite of death, recurrent myocardial infarction, refractory ischemia, or heart failure, assessed over a median follow-up of 4.2 years.
Main Results:
- The primary endpoint occurred in 21.3% of patients.
- Obstructive CAD, identified by CTA, was associated with a 1.74-fold higher risk of the primary endpoint compared to nonobstructive CAD (p=0.002).
- High-risk CAD by CTA showed a 1.56-fold increased risk (p=0.002), with similar trends observed for ICA.
Conclusions:
- Coronary CTA is equivalent to ICA for assessing long-term risk in patients with NSTEACS.
- CTA provides a reliable non-invasive method for risk stratification in this patient population.
- The VERDICT trial demonstrates the clinical utility of CTA in managing NSTEACS.
Background:
Severity and extent of coronary artery disease (CAD) assessed by invasive coronary angiography (ICA) guide treatment and may predict clinical outcome in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS).
Objectives:
This study tested the hypothesis that coronary computed tomography angiography (CTA) is equivalent to ICA for risk assessment in patients with NSTEACS.
Methods:
The VERDICT (Very Early Versus Deferred Invasive Evaluation Using Computerized Tomography in Patients With Acute Coronary Syndromes) trial evaluated timing of treatment in relation to outcome in patients with NSTEACS and included a clinically blinded coronary CTA conducted prior to ICA. Severity of CAD was defined as obstructive (coronary stenosis ≥50%) or nonobstructive. Extent of CAD was defined as high risk (obstructive left main or proximal left anterior descending artery stenosis and/or multivessel disease) or non-high risk. The primary endpoint was a composite of all-cause death, nonfatal recurrent myocardial infarction, hospital admission for refractory myocardial ischemia, or heart failure.
Results:
Coronary CTA and ICA were conducted in 978 patients. During a median follow-up time of 4.2 years (interquartile range: 2.7 to 5.5 years), the primary endpoint occurred in 208 patients (21.3%). The rate of the primary endpoint was up to 1.7-fold higher in patients with obstructive CAD compared with in patients with nonobstructive CAD as defined by coronary CTA (hazard ratio [HR]: 1.74; 95% confidence interval [CI]: 1.22 to 2.49; p = 0.002) or ICA (HR: 1.54; 95% CI: 1.13 to 2.11; p = 0.007). In patients with high-risk CAD, the rate of the primary endpoint was 1.5-fold higher compared with the rate in those with non-high-risk CAD as defined by coronary CTA (HR: 1.56; 95% CI: 1.18 to 2.07; p = 0.002). A similar trend was noted for ICA (HR: 1.28; 95% CI: 0.98 to 1.69; p = 0.07).
Conclusions:
Coronary CTA is equivalent to ICA for the assessment of long-term risk in patients with NSTEACS. (Very Early Versus Deferred Invasive Evaluation Using Computerized Tomography in Patients With Acute Coronary Syndromes [VERDICT]; NCT02061891).
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care

